Bayesian Capital Management’s Elevance Health ELV Stock Holding History

Bayesian Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,600	Closed	-$1.81M	–	255
2025 Q3	$1.81M	Buy	+5,600	New	+$1.74M	0.37%	79
2024 Q2	–	Sell	-2,510	Closed	-$1.3M	–	841
2024 Q1	$1.3M	Buy	2,510 +1,561	+164%	+$776K	0.12%	231
2023 Q4	$448K	Buy	+949	New	+$439K	0.05%	409
2023 Q1	–	Sell	-2,584	Closed	-$1.33M	–	878
2022 Q4	$1.33M	Buy	+2,584	New	+$1.31M	0.19%	124
2022 Q3	–	Sell	-1,762	Closed	-$850K	–	783
2022 Q2	$850K	Buy	+1,762	New	+$872K	0.16%	189
2021 Q1	–	Sell	-3,148	Closed	-$1.01M	–	578
2020 Q4	$1.01M	Buy	3,148 +2,146	+214%	+$659K	0.26%	101
2020 Q3	$269K	Buy	+1,002	New	+$270K	0.07%	372
2019 Q3	–	Sell	-6,261	Closed	-$1.77M	–	563
2019 Q2	$1.77M	Sell	6,261 -2,000	-24%	-$546K	0.37%	75
2019 Q1	$2.37M	Buy	8,261 +6,697	+428%	+$1.94M	0.46%	54
2018 Q4	$411K	Sell	1,564 -1,171	-43%	-$322K	0.08%	328
2018 Q3	$750K	Sell	2,735 -9,165	-77%	-$2.38M	0.12%	238
2018 Q2	$2.83M	Buy	11,900 +7,700	+183%	+$1.78M	0.64%	22
2018 Q1	$923K	Sell	4,200 -4,010	-49%	-$942K	0.23%	136
2017 Q4	$1.85M	Buy	+8,210	New	+$1.75M	0.38%	60
2017 Q3	–	Sell	-2,474	Closed	-$465K	–	527
2017 Q2	$465K	Buy	+2,474	New	+$445K	0.17%	198

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Bayesian Capital Management's ELV Position: Q4 2025 in Review

Bayesian Capital Management sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 5,600 shares — an estimated $1.81M sold.

Bayesian Capital Management first reported a position in ELV in Q2 2017 and held it in 15 quarters. The position peaked at $2.83M in Q2 2018. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

Bayesian Capital Management reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
Bayesian Capital Management sold 5,600 Elevance Health shares in Q4 2025, an estimated $1.81M.
Bayesian Capital Management first reported a position in Elevance Health in Q2 2017 and held it in 15 quarters.
Bayesian Capital Management's Elevance Health position peaked at $2.83M in Q2 2018.
1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.